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Abstract
Viable bacteria were sought in 44 Maki-negative biofilms from
central venous catheters (CVCs) using epifluorescence micros-
copy after live/dead staining. Thirty (77%) samples contained
viable but non-culturable (VBNC) cells; the majority were posi-
tive on real-time PCR specific for Staphylococcus epidermidis (one
also for Staphylococcus aureus). Viable cells were significantly
(p <0.01) associated with CVCs from febrile patients, three of
whom showed S. epidermidis-positive blood cultures, suggesting
that CVC-associated biofilms can be reservoirs for staphylococci
in the VBNC state. The possible role of VBNC staphylococci in
persistent infections related to medical devices requires further
investigation.
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Biofilm-related infections can persist for months, years, or
even throughout life and have a well-known role in chronic
disease pathogenesis [1–4]. They are among the major limita-
tions to long-term use of indwelling medical devices, because
of the well-established impaired susceptibility of biofilm-grow-
ing bacteria to current antibiotics [2,3,5,6]. Central venous
catheters (CVCs) are indwelling medical devices at high risk of
infection [1,3,4,7,8]. The hypothesis that bacterial clumps from
mature biofilm may become septic emboli that disperse via the
bloodstream is supported by in vitro catheter infection models
and by microbiological and clinical data [4,7,9].
Biofilm-growing bacterial cells live in unfavourable microen-
vironmental conditions such as nutrient and oxygen depletion
and pH and ionic strength variation, and may undergo transfor-
mation into slow-metabolism forms, including the Viable But
Non-Culturable (VBNC) state, characterized by a number of
molecular, structural and functional features [6,10–12].
The VBNC state is a transient dormancy condition aimed
at stress adaptation and associated with significant cell dwarf-
ing and failure to grow on culture media. Nonetheless VBNC
cells are alive, preserve a degree of metabolic activity and
can be ‘resuscitated’ to the culturable state by appropriate
stimulation [11,12]. The role of CVC-associated biofilms as
reservoirs for VBNC forms capable of regaining full cultura-
bility and virulence (after biofilm detachment) is therefore a
major question, also considering their possible involvement
in recurrent infections.
A total of 44 CVCs explanted from hospital patients from
November 2007 to February 2008, selected from devices
yielding no growth by the Maki procedure [13], were further
investigated for VBNC forms in associated biofilms. The
CVC implantation time ranged from 3 days to 3 months.
To detach any biofilm present on the catheter, the distal
5 cm of each CVC was subjected to three cycles of sonication
and vortexing, followed by resuspension in PBS (5 mL). Aliquots
of 200 lL were then inoculated in duplicate in 5 mL of tryptic
soy broth and observed for 72 h to confirm lack of growth.
Overall, 39/44 biofilms yielded no microbial growth (Non-
Culturable) and were investigated for viable bacterial cells by
staining 1 mL of each sample with a live/dead viability assay
using SYBR Green I 1· (Invitrogen, Eugene, OR, USA) and
40 mg/L propidium iodide (Sigma-Aldrich, St Louis, MO,
USA) and examining it with an epifluorescence microscope
at · 1000 magnification (Axioskop 2, Zeiss, Milan, Italy). Via-
ble bacteria in amounts ranging from 2.5 · 10/mL to
3 · 104/mL were detected in 30/39 (77%) samples (Fig. 1),
which were then analysed for bacterial DNA.
DNA was extracted from 1 mL aliquots using the Fast-
DNA SPIN kit for soil (Q-Biogene, Irvine, CA, USA) after
incubation with lysozyme (10 mg/mL) and lysostaphin
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(100 mg/L; both from Sigma-Aldrich) for 1 h at 37C and
used in real-time PCR assays targeting bacterial 16S rDNA
[14] and genes specific to Staphylococcus epidermidis [15] and
Staphylococcus aureus [16], the species growing most fre-
quently as CVC-associated biofilm [4,8,17,18].
The PCR assays targeting 16S rDNA were performed as
described previously using primer pair P891F and P1033R
[14]. Those targeting S. epidermidis and S. aureus were devel-
oped for this study using primer pairs Se705-1/Se705-2 [15]
and Sa442-1/Sa442-2 [16] and the following cycling condi-
tions: 95C for 3 min, followed by 40 cycles of 95C for
15 s, 54C (S. aureus) or 56C (S. epidermidis) for 20 s and
72C for 20 s. The ramping to generate melt curves was
0.5C/10 s. Reactions were run in a total volume of 25 lL
containing 5 lL DNA, 0.8 lM of each primer and Supermix
iQ SYBR Green 1·, using the iQ5 iCycler (both from Bio-
Rad Laboratories, Hercules, CA, USA). Samples were analy-
sed in triplicate together with crude extracts of a culture of
S. epidermidis ATCC 35984 or S. aureus ATCC 25923.
Twenty-six of the 30 biofilms harbouring viable cells were
positive on real-time PCR assays targeting bacterial 16S
rDNA; 19 (73%) were also positive on S. epidermidis-specific
PCR and one (NC14) contained both S. epidermidis-specific
and S. aureus-specific sequences (Fig. 1).
Blood culture results were also examined where available
(17/30 patients), S. epidermidis was recovered from three
patients, accounting for 18% of all CVCs carrying VBNCs
and for 27% (3/11) of those also positive for S. epidermidis
species-specific PCR.
To relate these data to actual clinical outcomes, findings
were compared with patient data, which were available for
26 patients from intensive-care units and haematology (the
wards where most of the CVCs had been collected). Patient
temperature, CVC implantation time and antibiotic therapy
administered were analysed. A significant (p <0.01; chi-
square test) correlation was found between high tempera-
ture (‡38C) and presence of viable cells, which were
detected in 81% of CVCs from febrile patients and 30% of
CVCs from non-febrile patients. Moreover, 62% of VNBC
cell-containing CVCs from febrile patients were positive for
S. epidermidis (Fig. 2), highlighting the proneness of this spe-
cies to colonize indwelling medical devices and its ability to
persist in a dormant state.
Biofilm involvement in chronic infections is well documented
[1,2,4,5,8,9]. Our findings demonstrate that CVC-associated
biofilms testing negative on routine microbiological assays can
nonetheless carry viable bacteria. The significant association
between VBNC forms and fever documented here suggests a
role for them in clinical symptoms, supposedly after resuscita-
tion and growth of a small number of non-culturable cells,
and stresses the value of molecular diagnostic tests in routine
FIG. 1. Number of viable cells/mL counted in central venous catheter (CVC) -associated biofilms and presence of sequences specific to bacterial
DNA, Staphylococcus epidermidis and Staphylococcus aureus in the 30 biofilms negative on culture tests (non-culturable; NC) and positive for viable
cells. No detection of 16S rDNA; Detection of 16S rDNA; Detection of 16S rDNA and species-specific sequences of S. epidermidis and
S. aureus (*).
FIG. 2. Percentage of central venous catheters (CVCs) from febrile
( ) and non-febrile ( ) patients found positive/negative for the pres-
ence of viable cells. The proportion of CVCs containing Staphylococ-
cus epidermidis species-specific gene is indicated as .
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microbiological investigations, at least when high-risk patients
are involved.
To our knowledge this is the first evidence that S. epidermi-
dis and S. aureus can enter the VBNC state. If positively
documented, their ability to persist in this state could help to
explain the well-known prevalence of both species in recur-
rent CVC-related infections [4,8,17,18]. Detection of S. epide-
rmidis in 62% of CVCs demonstrated to contain non-culturable
bacteria (removed from febrile patients, 27% of whom also
had a positive blood culture) supports this hypothesis.
Further research into the relationship among VBNC forms
found in CVC-associated biofilms, their actual metabolic
activity and recurrent infection, as well as careful recording
of concurrent clinical data, are required to gain insights into
the possible role of VBNC bacterial cells in indwelling medi-
cal device-related persistent infections.
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